Suvemcitug combined with chemotherapy significantly improved PFS and OS in platinum-resistant recurrent ovarian cancer, nearly doubling median PFS and extending median OS. The trial demonstrated ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Enhanced chemosensitivity: Laboratory data suggest PRP makes resistant pancreatic tumor cells more responsive to standard chemotherapies and alters the tumor microenvironment — including reduced ...

Kuhn, MD, MS, discussed lessons learned on shoulder instability from the Multicenter Orthopaedic Outcomes Network Shoulder ...

In this analysis of the phase 3 ALLTO trial, researchers explored 10-year outcomes of HR+, HER2+ early breast cancer patients who received either an aromatase inhibitor or a selective estrogen ...

The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer after they received neoadjuvant treatment and surgery predicted ...

Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.

Although 76% respondents reported encountering medical misinformation, that exposure was not significantly associated with clinically significant fear of cancer recurrence or self-reported treatment ...

Differentiating tunnel and abscess/inflammatory nodule recurrence refines surgical outcomes after wide excision in patients ...

Early dual antiplatelet therapy shows superior efficacy in reducing stroke recurrence compared with aspirin monotherapy.

Greenwich LifeSciences Inc. (NASDAQ: GLSI) stock is trading higher on Monday, with a session volume of 2.804 million compared to the average volume of 81.85 thousand, as per data from Benzinga Pro.

The average 30-year fixed mortgage rate rose slightly to 6.22% this week but remains below both the year-to-date average of 6.62% and the 6.60% rate seen a year ago. Freddie Mac economists say lower ...